1. HBW Insight
  2. >>Health
  3. >>Business

Sanitizer Demand Sparks Creativity: Compressed-Air Spray, ‘Shield’ Formula, Single-Use Convenience

 
• By Eileen Francis

COVID-19 drives hand sanitizer innovation as firms look to solve typical problems such as short microbe-kill treatment periods or risk of infection from sharing sanitizer bottles. Among launches, Breathe aerosol hand sanitizers use compressed air for faster application withouontact, while Disinfectant&Shield claims to kill germs for eight hours.

Hand sanitizer alcohol gel rub coronavirus virus protection on hands

Surging US demand for OTC hand sanitizers is spurring innovation in delivery and formulations that provide long-lasting microbe-kill capability, reduce the risk of person-to-person infection or offer easy-open, single-use convenience.

Products launched in response to the COVID-19 pandemic include Breathe continuous spray clean aerosol hand sanitizers that use compressed air...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Business

Prestige Consumer Starting Clear Eyes Production With No Contract Partner ‘Out There To Tap Into’

 
• By Malcolm Spicer

PCH lowers full-year guidance even after reaching $100m deal to acquire Canadian sterile ophthalmic manufacturer for its Clears Eyes line troubled by supply slumps for several years. Its $47.5m reported net sales for April-June period were down 6% from a year ago.

Futura Launches Eroxon Strategic Review

 
• By Tom Gallen

Weaker than expected sales of OTC ED treatment Eroxon has led Futura to launch a review of the brand's future direction.

Reducing ‘Complexity Across The Organization’ Tops Kenvue Interim CEO’s Priorities

 
• By Malcolm Spicer

Three weeks into his appointment as interim CEO, Kirk Perry sets priorities including “reduce organizational complexity,” “reinforce a consumer-centric mindset” and “refocus on household penetration.”

Softness In US And China Holds Back Bayer Consumer Health

 
• By Tom Gallen

Like its peers, Bayer Consumer Health has struggled in the challenging US market in the first half of 2025 and says it doesn't expect conditions to change this year.

More from Health

Softness In US And China Holds Back Bayer Consumer Health

 
• By Tom Gallen

Like its peers, Bayer Consumer Health has struggled in the challenging US market in the first half of 2025 and says it doesn't expect conditions to change this year.

Repeat Buyers Passing 50% Key For Opill Sales Leading Perrigo’s Women’s Health Growth

 
• By Malcolm Spicer

“We continue to grow the brand. It was slower than initially anticipated or forecasted in basis, but I'm pleased with how it's developing,” says CEO Patrick Lockwood-Taylor of Opill performance.

Recordati Benefits From Cough & Cold Rebound

 
• By Tom Gallen

OTC sales grew at Italy's Recordati in the first half of 2025, with an improving cough and cold picture contributing to the rise.